baber/WOPTO huggingface dataset:
Patent MX-2021005349-A (MX)
Title: Process for preparing triacetonamine.
Inventor: MINKE KATHARINA
IPC: C07D211/74
Filed: 2021-05-06
Abstract: An improved process can be used for preparing triacetonamine. The process involves performing an absorption step in which acetone present in the crude product is removed from triacetonamine by distillation, and in gaseous form is then absorbed in countercurrent into fresh, liquid acetone. The acetone stream thus obtained is then converted further to triacetonamine. This process enables more energy-efficient reutilization of the unreacted reactants used in the synthesis of triacetonamine, and thus lowers overall both the use of reactants and the energy expenditure.
Patent MX-2021006844-A (MX)
Title: Rivet dispenser reloading systems and methods of use thereof.
Inventor: SPINELLA DONALD J
IPC: B23K11/31
Filed: 2019-12-13
Abstract: Rivet dispenser reloading systems and methods of use thereof are provided. A non-limiting embodiment of a rivet dispenser reloading system comprises a receiving member defining a channel therein, and a first gate. The rivet receiving member comprises a first port and a second port that communicate with the channel. The first port is configured to receive rivets. The second port is configured to selectively engage with a rivet dispenser and introduce rivets to the rivet dispenser. The channel extends between the first port and the second port and is configured to transport rivets from the first port to the second port in a series arrangement and in a preselected orientation. The first gate is in communication with the second port and is selectively positionable between a first configuration inhibiting movement of rivets through the second port, and a second configuration enabling movement of rivets through the second port.
Patent MX-2021007531-A (MX)
Title: Cathodic arc ignition device.
Inventor: KRASSNITZER SIEGFRIED
IPC: H01J37/32
Filed: 2019-12-20
Abstract: An arc ignition device for cathodic arc deposition of a target material onto a substrate, comprising a trigger finger arranged moveable between a contacting position and a resting position, wherein in the contacting position a side surface of an adjacent target can be physically contacted by the trigger finger, and in the resting position the adjacent target cannot be contacted by the trigger finger, wherein during cathodic arc deposition of a target material, the trigger finger is arranged movable between the contacting position and the resting position in such a way that the contamination of the trigger finger with deposited target material during the cathodic arc deposition of the target material can be minimized.
Patent MX-2021009263-A (MX)
Title: Recovered plastic cards.
Inventor: MOSTELLER BARRY
IPC: B42D25/455
Filed: 2020-01-30
Abstract: A laminated transaction card may comprise post-consumer polyethylene with a thickness of at least 30% of a thickness of the laminated transaction card. A first polymer- based layer comprising polyvinyl chloride is coupled to a first surface of the core layer by a first adhesive layer. A second polymer-based layer comprising polyvinyl chloride is coupled to a second surface of the core layer by a second adhesive layer. The first adhesive layer and the second adhesive layer comprise an adhesive formulated to bond the post-consumer polyethylene and the polymer-based layers.
Patent MX-2021009316-A (MX)
Title: Operation method for terminal capability identification and communication device.
Inventor: KE XIAOWAN
IPC: H04W8/20
Filed: 2020-02-03
Abstract: Embodiments of the present disclosure provide an operation method for terminal capability identification and a communication device, the operation method includes: performing a first related operation of terminal capability identification, the first related operation of the terminal capability identification includes at least one of the following: deleting or suspending the terminal capability identification; changing the terminal capability identification of the first type in the terminal context to the terminal capability identification of the second type; and sending operation information of the terminal capability identification.
Patent MX-2021009852-A (MX)
Title: Human antibodies to pd-1.
Inventor: PAPADOPOULOS NICHOLAS J
IPC: A61K39/395
Filed: 2016-07-22
Abstract: The present invention provides antibodies that bind to the T-cell co-inhibitor programmed death- 1 (PD-1 ) protein, and methods of use. In various embodiments of the invention, the antibodies are fully human antibodies that bind to PD-1. In certain embodiments, the present invention provides multi-specific antigen-binding molecules comprising a first binding specificity that binds to PD-1 and a second binding specificity that binds to an autoimmune tissue antigen, another T- cell co-inhibitor, an Fc receptor, or a T-cell receptor. In some embodiments, the antibodies of the invention are useful for inhibiting or neutralizing PD-1 activity, thus providing a means of treating a disease or disorder such as cancer or a chronic viral infection. In other embodiments, the antibodies are useful for enhancing or stimulating PD-1 activity, thus providing a means of treating, for example, an autoimmune disease or disorder.
Patent MX-2021013833-A (MX)
Title: Methods and compositions comprising staphylococcus protein a (spa) variants.
Inventor: SCHNEEWIND OLAF
IPC: A61K39/085
Filed: 2020-05-13
Abstract: Embodiments concern methods and composition for preventing or treating a bacterial infection, particularly infection by a Staphylococcus bacterium. The embodiments concern improved non-toxigenic Protein A (SpA) variant.
Patent MX-2021014544-A (MX)
Title: Antibacterial aminoglycoside derivatives.
Inventor: DING CHARLES Z
IPC: A61K31/7028
Filed: 2020-05-29
Abstract: A new class of antibacterial aminoglycoside derivatives, pharmaceutical compositions containing such compounds, and application thereof in the preparation of drugs for treating diseases related to bacterial infections. Specifically disclosed are a compound represented by formula (II), pharmaceutically acceptable salts thereof, and isomers thereof.
Patent MX-2021015145-A (MX)
Title: Method for producing a high strength coated steel sheet having improved strength, formability and obtained sheet.
Inventor: FAN DONGWEI
IPC: C21D8/02
Filed: 2016-12-09
Abstract: A method for producing a high strength coated steel sheet having an improved ductility and an improved formability, the chemical composition of the steel containing: 0.13% â¤ C â¤ 0.22%, 1.9% â¤ Si â¤ 2.3%, 2.4% â¤ Mn â¤ 3%, Al â¤0.5%, Ti < 0.05 %, Nb < 0.05 %, the remainder being Fe and unavoidable impurities. The sheet is annealed at temperature TA higher than Ac3 but less than 1000Â°C for a time of more than 30 s, quenched by cooling to a quenching temperature QT between 200Â°C and 280Â°C in order to obtain a structure consisting of austenite and at least 50% of martensite, the austenite content being such that the final structure can contain between 3% and 15% of residual austenite and between 85% and 97% of the sum of martensite and bainite, without ferrite, heated up to a partitioning temperature PT between 430Â°C and 490Â°C and maintained at this temperature for a time Pt between 10 s and 100 s, hot dip coated and cooled to the room temperature.
Patent MX-2022002707-A (MX)
Title: Membrane permeate recycle process for use with pressure swing adsorption processes.
Inventor: RUSSELL BRADLEY P
IPC: B01D53/047
Filed: 2020-08-27
Abstract: Process of treating a net gas stream is disclosed. The process includes sending the net gas stream to a compressor to produce a compressed gas stream. The compressed gas stream is then sent to a pressure swing adsorption unit to produce a hydrogen product stream and a tail gas stream. Tail gas stream from the pressure swing adsorption unit is sent to a first membrane unit to produce a first permeate stream and a first non-permeate stream. Portion of the tail gas stream is sent to a second membrane unit to produce a second permeate stream and a second non-permeate stream.
Patent MX-2022002945-A (MX)
Title: Door latch, lock and open mechanism for medical device treatment system.
Inventor: LAMBERT SEAN
IPC: E05B57/00
Filed: 2020-08-31
Abstract: A latch and lock assembly includes a lever pivotable between a latched and unlatched position. A first actuator selectively moves a locking tab between a locked and unlocked position. In the locked position, the locking tab blocks pivotable movement of the lever from the latched position to the unlatched position. In the unlocked position, the locking tab allows pivotable movement of the lever from the latched position to the unlatched position. A second actuator selectively rotates a door opening tab between a first and second position when the locking tab is in the unlocked position is included. When the door opening tab is in the first position the lever is in a latched position, and when the door opening tab is rotated from the first position to the second position, the door opening tab abuts the lever and urges the lever from the latched position to the unlatched position.A latch and lock assembly includes a lever pivotable between a latched and unlatched position. A first actuator selectively moves a locking tab between a locked and unlocked position. In the locked position, the locking tab blocks pivotable movement of the lever from the latched position to the unlatched position. In the unlocked position, the locking tab allows pivotable movement of the lever from the latched position to the unlatched position. A second actuator selectively rotates a door opening tab between a first and second position when the locking tab is in the unlocked position is included. When the door opening tab is in the first position the lever is in a latched position, and when the door opening tab is rotated from the first position to the second position, the door opening tab abuts the lever and urges the lever from the latched position to the unlatched position. Aircraft capable of vertical takeoff and landing, hovering, and efficient forward flight are described. An aircraft includes two side mounted tiltable proprotors and a central rotor disposed above the proprotors. The proprotors are tiltable between at least a horizontal position for forward flight and a vertical position for vertical or hovering flight. The central rotor may be powered for vertical and transitional flight modes and may turn by free autorotation during forward flight. The proprotors may be differentially tilted during vertical or hovering flight to counter torque effects of the central rotor. The central rotor may be foldable and/or easily detachable from the aircraft to facilitate storage and transportation.
Patent MX-2022003845-A (MX)
Title: Medicinal cognitive treatments.
Inventor: MILLER TAMARA DIANE
IPC: A61K31/46
Filed: 2020-09-30
Abstract: The present disclosure generally relates to a method of improving cognition and/or treating cognitive decline in a cognitively healthy subject comprising administering to the cognitively healthy subject a therapeutically effective amount of a compound of Formula I, such as Xanamem (also known as UE2343), or a pharmaceutically acceptable salt, solvate or prodrug thereof, as described herein.
Patent MX-2022005160-A (MX)
Title: Oxysterols and methods of use thereof.
Inventor: SALITURO FRANCESCO G
IPC: C07J9/00
Filed: 2019-04-17
Abstract: Compounds are provided according to Formula (A): and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof; wherein R1, R2, R3, R4, R5, R6, and RG are as defined herein. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of conditions.
Patent MX-2022005226-A (MX)
Title: Coding device, decoding device, coding method, decoding method, and picture compression program.
Inventor: LIM CHONG SOON
IPC: H04N19/119
Filed: 2020-11-13
Abstract: A coding device (100) performs division into a plurality of blocks by using a block division mode set obtained by combining one or more block division modes which define division types. The block division mode set comprises: a first block division mode in which the number of divisions and the dividing direction for dividing a first block are defined; and a second block division mode in which the number of divisions and the dividing direction for dividing a second block, which is one of blocks acquired by dividing the first block are defined. When a division in the first block mode results in three blocks, the second block is the center block among the blocks acquired by dividing the first block, and the dividing direction of the second block division mode is the same as the dividing direction of the first block division mode, then the second block division mode includes only a block division mode in which a division results in three blocks.
Patent MX-2022006304-A (MX)
Title: Compositions and methods for inhibiting the biological activity of soluble biomolecules.
Inventor: HAWTHORNE LOUIS
IPC: A61K38/19
Filed: 2017-03-24
Abstract: The disclosure provides, among other things, compositions that bind to and inhibit the biological activity of soluble biomolecules, as well as pharmaceutical compositions thereof. Also provided herein are a number of applications (e.g., therapeutic applications) in which the compositions are useful.
Patent MX-2022008983-A (MX)
Title: Aziridine functional compound.
Inventor: TENNEBROEK RONALD
IPC: C08G18/22
Filed: 2021-01-21
Abstract: The present application relates to aziridine functional compounds with reduced genotoxicity and good crosslinking efficiency, for use in the preparation of, for example, coatings.
Patent MX-2022009329-A (MX)
Title: A continuous flow process for preparation of acephate and its intermediates.
Inventor: KINI PRASHANT VASANT
IPC: C07F9/02
Filed: 2021-01-25
Abstract: The present invention relates to a continuous flow process for synthesis of acephate and its intermediates. The present invention more particularly relates to synthesis of acephate and its intermediates in a microreactor system.
Patent MX-2022010168-A (MX)
Title: Calpain modulators and therapeutic uses thereof.
Inventor: EMAYAN KUMARASWAMY
IPC: C07D403/14
Filed: 2019-03-25
Abstract: Disclosed herein are small molecule calpain modulator compositions, pharmaceutical compositions, the use and preparation thereof.
Patent MX-2022010666-A (MX)
Title: Type vi-e and type vi-f crispr-cas system and uses thereof.
Inventor: Zhou Yingsi
IPC: C12N15/90
Filed: 2020-02-28
Abstract: Provided are novel CRISPR/Cas compositions and uses thereof for targeting nucleic acids. In particular, provided are non-naturally occurring or engineered RNA-targeting systems comprising a novel RNA-targeting Cas13e or Cas13f effector protein, and at least one targeting nucleic acid component such as a guide RNA (gRNA) or crRNA. The novel Cas effector proteins are among the smallest of the known Cas effector proteins, at about 800 amino acids in size, and are thus uniquely suitable for delivery using vectors of small capacity, such as an AAV vector.
Patent MX-2022011069-A (MX)
Title: Variable-q antenna coil circuit for rfid applications.
Inventor: TROESCH PETER
IPC: H01Q1/22
Filed: 2021-03-05
Abstract: A passive radio frequency identification (RFID) reader is configured to dynamically vary the Q factor of its resonant antenna coil circuit in order to optimize its performance under different conditions. This RFID reader suitably provides optimal performance for both transponder reading and transponder writing operations, rather than being designed for optimal performance for only one operation or the other, or some fixed compromise between them.
Patent MX-2022012178-A (MX)
Title: Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use.
Inventor: LIU BINGCAN
IPC: A61P35/00
Filed: 2021-04-01
Abstract: Disclosed are compounds and pharmaceutically acceptable salts thereof that may be used in the treatment of subjects in need thereof. The compounds disclosed herein may be inhibitors of tyrosine and threonine-specific cdc2-inhibitory kinase (Myt1). Also disclosed are pharmaceutical compositions containing the compounds or pharmaceutically acceptable salts thereof and methods of their preparation and use.
Patent MX-2022013873-A (MX)
Title: Ring closing synthesis of macrocyclic mcl-1 inhibitor intermediates.
Inventor: HUANG LIANG
IPC: A61P35/00
Filed: 2021-05-05
Abstract: Provided herein are processes for synthesizing Mcl-1 inhibitors and intermediates such as compound F that can be used to prepare them where the variable PG is as defined herein. In particular, provided herein are processes for synthesizing compound A1, and salts or solvates thereof and compound A2, and salts and solvates thereof.
Patent MX-2022016467-A (MX)
Title: Thread clearance.
Inventor: HAMMARGREN JOHN
IPC: E21B17/02
Filed: 2021-06-29
Abstract: A female portion to form part of a thread joint for a percussive drilling tool comprising a mounting sleeve having an axial end, wherein the mounting sleeve surrounds an internal cavity having an axial inner wall at the opposing end of the mounting sleeve compared to the axial end; wherein the mounting sleeve has at least one substantially cylindrical internally threaded section having a length L<sub>1</sub>, a thread entrance towards the axial end and a thread exit towards the axial inner wall; a thread clearance section positioned between the axial inner wall and the thread exit having a length L<sub>2</sub> and a diameter D<sub>1</sub>; a guiding section positioned between the thread entrance and the axial end of the sleeve having a length, L<sub>3</sub>; characterized in that: 0 mm < L<sub>3</sub>-L<sub>2</sub> < 12 mm.
Patent MX-PA00006605-A (MX)
Title: Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents.
Inventor: SHIGEO HAYASHI
IPC: C07D403/06
Filed: 1999-07-02
Abstract: This invention provides a compound of the following formula:or the pharmaceutically acceptable salts thereof wherein A is C 1-6 alkylene or -NR1-; Z is C(=L)R2, or SO2R3; U is CH or N; W and Y are independently selected from -CH2-, O, S and -N-R1; m is 1, 2 or 3; q and r are independently 0, 1 or 2; X is independently selected from halogen, C1-4 alkyl, halo-substituted C1-4 alkyl, hydroxy, C1-4 alkoxy, halo-substituted C1-4 alkoxy or the like; n is 1 or 2; L is oxygen or sulfur; R1 is hydrogen or C1-4 alkyl; R2 is hydroxy, C1-6alkyl, halo-substituted C1-6 alkyl, C1-6 alkoxy, halo-substituted C1-6 alkoxy, C3-7 cycloalkoxy, C1-4 alkyl(C3-7 cycloalkoxy), -NR4R5 or the like; R3 is C1-6 alkyl or halo-substituted C1-6 alkyl; and R4 and R5 are independently selected from hydrogen, C1-6 alkyl and halo-substituted C1-6alkyl.This invention also provides a pharmaceutical composition useful for the treatment of a medical condition in which prostaglandins are implicated as pathogens.
Patent MX-PA00009649-A (MX)
Title: Targeted advertisement using television delivery systems.
Inventor: MCCOSKEY JOHN S
IPC: H04N21/25
Filed: 1999-04-01
Abstract: A novel multiple channel architecture (265) is designed to allow targeted advertising directed to television terminals (220) connected to an operations center (202) or a cable headend (208). Program channels carry television programs. The invention uses upstream data reception hardware (262, 275, 297), databases (301) and processing hardware (285, 293) and software to accomplish these functions. During commercial breaks in the television programs, advertisements, which are also broadcast on the program channel, are displayed. However, additional feeder channels carry alternate advertising that may be better suited for certain viewing audiences. The operations center (202) or the cable headend (208) generate a group assignment plan (293, 299) that assigns the television terminals (220) to groups, based on factors such as area of dominant influence and household income. A switching plan (291) is then generated that instructs the television terminals (220) to remain with the program channel or to switch to one of the alternate feeder channels during the program breaks. The television terminals (220) record which channels were viewed during the program breaks, and report this information to the cable headend (208) and the operations center (202). The reported information is used to generate billing for commercial advertisers, and to analyze viewer watching habits.
Patent MX-PA01007710-A (MX)
Title: Freeze-dried agent containing paramylon, production and utilization thereof.
Inventor: SUWELACK WOLFGANG
IPC: A23L33/10
Filed: 2000-02-08
Abstract: The invention relates to an agent characterized in that it contains 0.1 to 100 weight percent of freeze-dried paramylon. The invention also relates to the production and utilization of said agent.
Patent MX-PA01009045-A (MX)
Title: Runner for injection holding.
Inventor: JOHN RICHARD WHITE
IPC: B29K21/00
Filed: 2001-09-07
Abstract: The invention is directed to the structure of an inline runner (12) for injection molding which uniformly increases the temperature of the injected compound as the compound flows from the injection port to single or multiple drop gates (14) at the entrance to single or multiple injection mold cavities. The inline runner has two opposing series of parallel channels formed into the runner (16) for the purpose of mixing the compound as it flows through the runner (12).
Patent MX-PA01010458-A (MX)
Title: Rapid hardening, ultra-high early strength portland-type cement compositions, novel clinkers and methods for their manufacture.
Inventor: KUNBARGI HASSAN
IPC: C04B7/345
Filed: 2000-03-21
Abstract: Clinkered materials containing high concentrations of {(C,K,N,M)4 (A,F,Mn,P,T,S)3 Cl,+E,ovs S+EE )}(crystal X), and {C2S)3 (C+E,ovs S+EE )3 C(f,Cl)} or C10S3+E,ovs S+EE 3(f,cl) (crystal Y), and/or {C5S2+E,ovs S+EE ) (crystal Z) directly from the kiln, rapidly hardening ultra-high early strength cement including these clinkered materials, methods for forming and using said compositions and the cements so produced are claimed. The methods include the steps of forming a mixture of raw material containing CaO, MgO, Al2O3, Fe2O3, TiO2, Mn2O5, SiO2, SO3, Na2O, K2O, P2O5 and F, respectively designated C, M, A, F, T, Mn, S, +E,ovs S+EE , N, K, P and f, and heating said mixture to an elevated temperature between 900 DEG  C. and 1,200 DEG  C.; before determining average amount of crystals X, Y, and Z. Final mixtures comprising these clinkers and hydraulic or portland type cement are made to produce cement compositions having crystal X concentrations of approximately 5% to 35% by weight, crystal Y concentrations of approximately 5% to 40% by weight, and/or crystal Z concentrations of approximately 5% to 40% by weight, with the remainder being hydraulic or portland type cement. The cements so produced are rapid hardening and exhibit high strengths ranging from 2,000 psi to 7,000 psi in one hour, 6,000 to 8,000 psi in one day and 9,000 to 12,000 psi in 28 days. They are sulfate and sea-water attack resistant and have low heats of hydration, minimal shrinkage, and high water impermeability. The methods claimed also results in significant reduction in gaseous emissions including SOx, NOx and COx.